All 57 PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) Holdings
There are 57 PBPH holdings. Top 10 companies weight: 62.35%.
Total Market Cap: $3.62T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (57 stocks) | +14.82% | 28.49 | 20.79 | 0.36 | +10.99% | +19.26% | 0.54 | ||||||||||
1 | LLY | Eli Lilly And Co | 15.65% | $1,146.37 | $1.03T | Drug Manufacturers - General | Healthcare | +29.14% | 48.44 | 33.67 | 0.19 | N/A | N/A | 71 | +10.82% | $1.27K | +38.32% | 0.65 |
2 | JNJ | Johnson & Johnson | 9.67% | $248.94 | $595B | Drug Manufacturers - General | Healthcare | +11.59% | 22.09 | 21.74 | 4.95 | N/A | N/A | 70 | +8.44% | $270 | +11.07% | N/A |
3 | ABBV | Abbvie Inc | 7.05% | $253.44 | $432B | Drug Manufacturers - General | Healthcare | -19.65% | 139.08 | 18.02 | 0.40 | N/A | N/A | 74 | +5.18% | $267 | +21.10% | 0.28 |
4 | MRK | Merck & Co Inc | 4.89% | $124.40 | $292B | Drug Manufacturers - General | Healthcare | +5.37% | 26.93 | 47.17 | 6.13 | N/A | N/A | 68 | +7.75% | $134 | +13.73% | 0.29 |
5 | n/a | Roche Holding Ag Ordinary Shares New | 4.50% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
6 | n/a | Novartis Ag Registered Shares | 4.45% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
7 | AMGN | Amgen Inc | 4.39% | $364.17 | $193B | Drug Manufacturers - General | Healthcare | +3.49% | 24.75 | 16.47 | 0.79 | N/A | N/A | 60 | -2.07% | $357 | +11.73% | 0.46 |
8 | AZN:XLON | Astrazeneca Plc | 4.35% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
9 | GILD | Gilead Sciences Inc | 3.71% | $133.21 | $164B | Drug Manufacturers - General | Healthcare | +98.59% | 17.75 | 15.22 | 0.32 | N/A | N/A | 74 | +18.83% | $158 | +18.49% | 0.35 |
10 | n/a | Novo Nordisk As Class B | 3.69% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
11 | PFE | Pfizer Inc | 3.15% | $24.75 | $141B | Drug Manufacturers - General | Healthcare | -6.35% | 11.65 | 8.58 | 0.09 | N/A | N/A | 58 | +16.32% | $29 | -4.84% | 0.38 |
12 | VRTX | Vertex Pharmaceuticals Inc | 3.04% | $480.50 | $121B | Biotechnology | Healthcare | +9.89% | 27.99 | 25.45 | 1.72 | N/A | N/A | 72 | +15.39% | $554 | +19.61% | 0.49 |
13 | BMY | Bristol-myers Squibb Co | 2.70% | $60.18 | $120B | Drug Manufacturers - General | Healthcare | +5.08% | 13.82 | 9.59 | 1.54 | N/A | N/A | N/A | N/A | N/A | +1.92% | N/A |
14 | n/a | Gsk Plc | 2.27% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
15 | n/a | Sanofi Sa | 2.13% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
16 | REGN | Regeneron Pharmaceuticals Inc | 1.50% | $672.15 | $69B | Biotechnology | Healthcare | +20.31% | 15.86 | 15.08 | 88.04 | N/A | N/A | 72 | +21.87% | $819 | +3.03% | 0.60 |
17 | n/a | Bayer Ag | 1.37% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
18 | n/a | Argenx Se | 1.33% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
19 | n/a | Takeda Pharmaceutical Co Ltd | 1.15% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
20 | n/a | Csl Ltd | 1.02% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
21 | ALNY | Alnylam Pharmaceuticals Inc | 0.94% | $272.67 | $37B | Biotechnology | Healthcare | N/A | 117.96 | 30.49 | 0.52 | N/A | N/A | 74 | +59.47% | $435 | +8.65% | 0.81 |
22 | n/a | Teva Pharmaceutical Industries Ltd | 0.91% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
23 | NTRA | Natera Inc | 0.86% | $262.63 | $40B | Diagnostics & Research | Healthcare | -11.74% | N/A | N/A | N/A | N/A | N/A | 77 | +7.43% | $282 | +17.53% | 1.29 |
24 | n/a | Sandoz Group Ag Registered Shares | 0.83% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
25 | n/a | Ucb Sa | 0.82% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
26 | RVMD | Revolution Medicines Inc Ordinary Shares | 0.76% | $180.39 | $37B | Biotechnology | Healthcare | +30.12% | N/A | N/A | N/A | N/A | N/A | 78 | +11.15% | $201 | +42.94% | 1.09 |
27 | BIIB | Biogen Inc | 0.73% | $199.95 | $29B | Drug Manufacturers - General | Healthcare | -15.32% | 17.41 | 14.75 | 0.64 | N/A | N/A | 65 | +13.17% | $226 | -9.14% | 0.51 |
28 | ZTS | Zoetis Inc Class A | 0.71% | $76.20 | $31B | Drug Manufacturers - Specialty & Generic | Healthcare | +10.56% | 12.08 | 11.20 | 1.05 | N/A | N/A | 67 | +50.60% | $115 | -16.45% | 0.56 |
29 | n/a | Otsuka Holdings Co Ltd | 0.67% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
30 | n/a | Chugai Pharmaceutical Co Ltd | 0.66% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
31 | ILMN | Illumina Inc | 0.65% | $184.68 | $29B | Diagnostics & Research | Healthcare | -6.80% | 44.12 | 35.59 | 3.34 | N/A | N/A | 60 | -9.23% | $168 | -16.96% | 1.00 |
32 | MRNA | Moderna Inc | 0.64% | $59.49 | $27B | Biotechnology | Healthcare | N/A | N/A | 23.04 | N/A | N/A | N/A | 46 | -18.88% | $48 | -28.62% | 1.37 |
33 | n/a | Haleon Plc | 0.61% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
34 | n/a | Daiichi Sankyo Co Ltd | 0.61% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
35 | INCY | Incyte Corp | 0.54% | $115.65 | $23B | Biotechnology | Healthcare | +27.16% | 15.82 | 15.06 | N/A | N/A | N/A | 61 | -1.58% | $114 | +7.88% | 0.57 |
36 | INSM | Insmed Inc | 0.54% | $107.02 | $24B | Biotechnology | Healthcare | +12.24% | N/A | 16.37 | 1.09 | N/A | N/A | 80 | +83.50% | $196 | +32.69% | 0.77 |
37 | UTHR | United Therapeutics Corp | 0.53% | $529.34 | $22B | Drug Manufacturers - Specialty & Generic | Healthcare | +26.56% | 17.96 | 19.49 | 1.91 | N/A | N/A | 75 | +25.34% | $663 | +23.70% | 0.41 |
38 | n/a | Astellas Pharma Inc | 0.52% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
39 | n/a | Merck Kgaa | 0.50% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
40 | RPRX | Royalty Pharma Plc Class A | 0.49% | $57.30 | $25B | Biotechnology | Healthcare | N/A | 28.69 | 48.08 | 1.32 | N/A | N/A | 75 | +4.53% | $60 | +9.29% | 0.25 |
41 | VTRS | Viatris Inc | 0.44% | $16.99 | $19B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 7.02 | 0.14 | N/A | N/A | 60 | +4.83% | $18 | +8.31% | 0.79 |
42 | NBIX | Neurocrine Biosciences Inc | 0.40% | $173 | $17B | Drug Manufacturers - Specialty & Generic | Healthcare | +9.25% | 25.72 | 24.10 | 0.21 | N/A | N/A | 75 | +15.75% | $200 | +12.11% | 0.79 |
43 | n/a | Genmab As | 0.39% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
44 | ROIV | Roivant Sciences Ltd Ordinary Shares | 0.39% | $34.05 | $25B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +15.48% | $39 | 0.00% | 0.90 |
45 | JAZZ | Jazz Pharmaceuticals Plc | 0.34% | $243.47 | $15B | Biotechnology | Healthcare | N/A | N/A | 13.51 | 0.96 | N/A | N/A | 78 | +7.51% | $262 | +6.61% | 0.72 |
46 | EXEL | Exelixis Inc | 0.31% | $55.53 | $14B | Biotechnology | Healthcare | +72.24% | 17.54 | 17.70 | 0.45 | N/A | N/A | 59 | -8.28% | $51 | +26.67% | 0.52 |
47 | n/a | Roche Holding Ag Bearer Shares | 0.29% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
48 | ELAN | Elanco Animal Health Inc | 0.29% | $25.13 | $13B | Drug Manufacturers - Specialty & Generic | Healthcare | -17.32% | N/A | 23.47 | 4.04 | N/A | N/A | 80 | +18.82% | $30 | -6.77% | 1.35 |
49 | n/a | Galderma Group Ag Registered Shares | 0.28% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
50 | n/a | Shionogi & Co Ltd | 0.28% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) Sector Allocation
HEALTHCARE
67.10%MATERIALS
4.40%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%